Renyuan Biotechnology

Explore the latest insights on Renyuan Biotechnology and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Renyuan Biotechnology’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Everest Medicines Signs Strategic Cooperation Agreement with Hi-Sen Pharmaceutical to Supply and Commercialize Six Products in China
CompanyDeals

Everest Medicines Signs Strategic Cooperation Agreement with Hi-Sen Pharmaceutical to Supply and Commercialize Six Products in China

Everest Medicines (HKG: 1952) announced that it has entered into a strategic cooperation framework agreement with Hi‑Sen Pharmaceutical, establishing a framework for the supply, distribution, and related manufacturing and commercialization…

InventisBio's Oral TYK2 Inhibitor Nomelcitinib Meets Primary Endpoint in Phase III Trial for Moderate-to-Severe Plaque Psoriasis – PASI 90 Above 70% at Week 16

InventisBio’s Oral TYK2 Inhibitor Nomelcitinib Meets Primary Endpoint in Phase III Trial for Moderate-to-Severe Plaque Psoriasis – PASI 90 Above 70% at Week 16

Nuance Pharma Doses First Participant in REACH Phase III Trial of STG320 for House Dust Mite Allergic Rhinitis in China

Nuance Pharma Doses First Participant in REACH Phase III Trial of STG320 for House Dust Mite Allergic Rhinitis in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
OBiO Technology and Renyuan Biotechnology Forge Deep Strategic Collaboration – Advancing EPC Cell Therapy from Preclinical CMC to IND Filing
CompanyDeals

OBiO Technology and Renyuan Biotechnology Forge Deep Strategic Collaboration – Advancing EPC Cell Therapy from Preclinical CMC to IND Filing